WALFISH PAUL has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are SUZHOU IND PARK MICRODIAG BIOMEDICINE TECHNOLOGY CO LTD, PACIFIC EDGE LTD and PROCREA BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 2 | |
#5 | China | 1 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ralhan Ranju | 20 |
#2 | Walfish Paul | 19 |
#3 | Siu K W Michael | 5 |
#4 | Colgan Terence J | 2 |
#5 | De Souza Leroi V | 2 |
#6 | Romaschin Alexander D | 1 |
#7 | Matta Ajay | 1 |
#8 | Romaschin Alexander J | 1 |
#9 | Desouza Leroi V | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016106453A1 | Nuclear ep-icd as a prognosis marker for prostate cancer | |
EP3077812A1 | Methods for the prognosis of breast cancer | |
US2015094224A1 | Methods for the diagnosis or prognosis of breast cancer | |
US2015057169A1 | Biomarkers for Head-and-Neck Cancers and Precancers | |
US2014187438A1 | Methods and Compositions for the Diagnosis and Treatment of Epithelial Cancers | |
US2012214165A1 | Methods and compositions for the diagnosis and treatment of thyroid cancer | |
WO2011137519A1 | Methods and compositions for the diagnosis and treatment of thyroid cancer | |
EP2567235A1 | Method for the diagnosis of epithelial cancers by the detection of epicd polypeptide | |
EP2480687A1 | Methods and compositions for the diagnosis and treatment of thyroid cancer | |
EP2087152A1 | Endometrial biomarkers |